Business
ProAxsis Partnership - US National Jewish Health
ProAxsis Partnership - US National Jewish Health.
About this update from Emv Capital Plc
[{"type":"text","content":"\n \nRNS Number : 7687U NetScientific PLC 27 October 2017 \n\n \nNetScientific plc\n(\"NetScientific\" or the \"Company\" or the \"Group\")\n \nProAxsis to initiate clinical trial partnership with National Jewish Health for its ProteaseTag® Technology in Cystic Fibrosis and Chronic Obstructive Pulmonary Disease Patients\n \nLondon, UK - October 27th 2017 - NetScientific plc (\"NetScientific\", AIM:NSCI), the transatlantic healthcare IP commercialisation group, provides an update on its portfolio company ProAxsis, which today announces that it has entered into a clinical trial partnership with National Jewish Health (\"NJH\"), the leading respiratory hospital in the United States.\nUnder the agreement ProAxis and NJH will work together in validating ProAxsis' ProteaseTag® point-of-care technology for real-time management of small airway inflammation in a spectrum of respiratory diseases including cystic fibrosis and COPD.\nCommenting on the news, Francois Martelet, Chief Executive Officer of NetScientific and Chairman of ProAxsis, said: \"We are delighted to note this US partnership with National Jewish Health, one of the world's leading hospitals in respiratory disease. The partnership brings tremendous resources and expertise and validates ProAxsis' technology as a potential industry leader for respiratory diagnostics. Our portfolio company, ProAxsis is very excited to work closely with NJH as they continue to make commercial progress.\"\n \nNetScientific holds a 57% stake on a fully diluted basis in ProAxsis.\n \nThe full text of the announcement from ProAxsis can be found below.\n \n \n# # #\n \nFor more information, please contact:\n \n\n\n\n\n NetScientific\n François R. Martelet, M.D., CEO\n Ian Postlethwaite, CFO\n\n\nTel: +44 (0)20 3514 1800\n\n\n\n\n \n Consilium Strategic Communications\n Mary-Jane Elliott / Jessica Hodgson /\n Chris Welsh / Laura Thornton \n \n\n\n \nTel: +44 (0)20 3709 5700\[email protected]\n\n\n\n\nStifel Nicolaus Europe Limited (NOMAD and Broker)\nJonathan Senior / David Arch / Ben Maddison\n\n\n Tel: +44 (0) 20 7710 7600\n\n\n\n\n \n \nProAxsis to test ProteaseTag® Technology in Cystic Fibrosis and Chronic Obstructive Pulmonary Disease ...